Business Wire

Great Lakes Brewing Company Quenches Increased Demand with Manufacturing Analytics Solution from Rockwell Automation

Del

Craft beer is booming business in the United States, and even seasoned breweries are finding themselves looking for creative ways to keep up with thirsty consumers. Cleveland-based Great Lakes Brewing Company (GLBC), an independent craft brewery founded in 1988, recently tapped into new manufacturing analytics technology that helps scale production without sacrificing product quality.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170724006189/en/

Microsoft technology and Rockwell Automation's manufacturing analytics solution enables Great Lakes  ...

Microsoft technology and Rockwell Automation's manufacturing analytics solution enables Great Lakes Brewing staff to identify and address equipment challenges in real time. (Photo: Business Wire)

GLBC deployed the FactoryTalk Analytics for Devices appliance from Rockwell Automation to bring the power of the internet of things (IoT) and analytics to its factory floor. The technology gives GLBC greater insight into the health of its beer-brewing machinery to help increase efficiency, improve quality, and minimize downtime.

“From day one, Great Lakes Brewing Company has been committed to good beer, which means we are relentlessly focused on quality – from the ingredients we use to our production process and beyond,” said John Blystone, electrical and control supervisor, Great Lakes Brewing Company. “Adding advanced analytics and hardware diagnostics to our factory floor allows us to continue fulfilling our quality commitment by giving us more meaningful insight into our production equipment.”

The solution provides health and diagnostic analytics from devices on the brewery’s plant floor. Inside the Rockwell Automation appliance there is a bot called “Shelby” that can interact with production staff using natural language processing. This technology is based on the Microsoft Bot Framework and trained with Microsoft Cognitive Services to help enable brewery staff to easily identify and address equipment challenges in real time.

“Shelby has been instrumental in our transition to a more connected plant floor environment, allowing us to tap into a wealth of existing data to solve problems very quickly,” Blystone said.

The solution deployed by GLBC is one component of a joint technology collaboration between Rockwell Automation and Microsoft designed to help companies make the most of digital transformation.

“Great Lakes Brewing Company’s solution is part of a broader trend of digital transformation that is helping support the continued growth of industry in the U.S.,” said Frank Kulaszewicz, senior vice president, Architecture and Software, Rockwell Automation. “By arming engineers with actionable data and insights, this technology is enhancing the great work they’re already doing and empowering them to create even better products.”

“Our work with Rockwell Automation has enabled manufacturing companies to transform their business using data and deep analytics to improve efficiency and productivity,” said Sam George, director, Azure IoT at Microsoft Corp. “It’s great to see the differentiated solutions our long-standing alliance is providing for industrial and manufacturing customers.”

To learn more about how Great Lakes Brewing Company is using scalable analytics to benefit its operations, watch this video from Rockwell Automation and Microsoft: https://www.youtube.com/watch?v=qaLpnJTCXyE

About Great Lakes Brewing Company

Great Lakes Brewing Company is Ohio’s original craft brewery, founded in 1988 by brothers Patrick and Daniel Conway. We celebrate the abundance of the Great Lakes region in every beer, dish, and story we share. For more information visit greatlakesbrewing.com.

About Rockwell Automation

Rockwell Automation Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and information, makes its customers more productive and the world more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 22,000 people serving customers in more than 80 countries.

Contact information

Rockwell Automation
Keith Lester
414-382-4871

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses20.11.2017 00:01Pressemelding

Shell and bio-bean announce that together they are helping to power some of London’s buses using a biofuel made partly from waste coffee grounds. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005060/en/ Shell and bio-bean announce that together they are helping to power some of London's buses using a biofuel made partly from waste coffee grounds (Photo: Business Wire) The B20 biofuel contains a 20% bio-component which contains part coffee oil. The biofuel is being added to the London bus fuel supply chain and will help to power some of the buses; without need for modification. Biofuel provides a cleaner, more sustainable energy solution for buses across London’s network by decreasing emissions1. “Our Coffee Logs have already become the fuel of choice for households looking for a

Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®19.11.2017 22:21Pressemelding

Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) marketing authorization of ONTRUZANT ® , a biosimilar referencing Herceptin ® (trastuzumab), for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer. ONTRUZANT ® is the first trastuzumab biosimilar to receive regulatory approval in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005066/en/ Christopher Hansung Ko, President & CEO of Samsung Bioepis. (Photo: Business Wire) The EC approval of ONTRUZANT ® applies to all 28 European Union (EU) member states and the European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein. ONTRUZANT ® will be commercial

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31Pressemelding

Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00Pressemelding

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20Pressemelding

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11Pressemelding

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom